<DOC>
	<DOCNO>NCT01984814</DOCNO>
	<brief_summary>The effect autologous bone marrow mononuclear cell duration survival Amyotrophic Lateral Sclerosis patient .</brief_summary>
	<brief_title>Stem Cell Therapy Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Survival duration Amyotrophic Lateral Sclerosis patient receive cellular transplantation compare patient receive cellular transplantation . Kaplan-Meier survival analysis use comparison .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients diagnose definite amyotrophic lateral sclerosis . Clear information date onset symptom , document contact information follow information Patients diagnose Progressive Lateral sclerosis , Progressive bulbar plasy , Progressive spinal muscular atrophy , Progressive muscular atrophy , monomelicamyotrophy madras motor neuron disease . patient comorbidities like presence acute infection Human Immunodeficiency Virus/Hepatitis B Virus/Hepatitis C Virus , malignancy , bleed tendency , renal failure , severe liver dysfunction acute medical condition respiratory infection pyrexia .</criteria>
	<gender>All</gender>
	<minimum_age>26 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>